Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Julie K Silver, assistant professor
  1. Harvard Medical School, Framingham, MA 01702, USA
  1. jksilver{at}bics.bwh.harvard.edu

    Evidence so far is promising, yet the optimal programme is unclear

    The benefits of exercise in people with cardiovascular disease are well documented,1 but its effect in people with cancer is less well studied. This is largely because research into the effects of exercise in preventing and recovering from heart attacks and strokes has been studied for much longer.

    In this week's BMJ, a randomised controlled trial by Mutrie and colleagues assesses the functional and psychological effects of a 12 week exercise programme in women with early stage breast cancer.2 It found no significant difference in the primary outcome of quality of life at 12 weeks as measured by the functional assessment of cancer therapy (FACT-G) questionnaire. However, it did find significant …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular